Second Sight Medical Products Company Profile (NASDAQ:EYES)

About Second Sight Medical Products (NASDAQ:EYES)

Second Sight Medical Products logoSecond Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company's product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. It does not restore normal vision and it does not slow or reverse the progression of the disease. The Company's Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals. The Argus II System works by converting video images captured by a miniature camera housed in a patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes that are implanted on the surface of the retina.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Devices & Implants
  • Sub-Industry: N/A
  • Symbol: NASDAQ:EYES
  • CUSIP: N/A
  • Web: www.secondsight.com
Capitalization:
  • Market Cap: $73.84 million
  • Outstanding Shares: 56,365,000
Average Prices:
  • 50 Day Moving Avg: $1.16
  • 200 Day Moving Avg: $1.48
  • 52 Week Range: $1.06 - $4.55
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.47
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $3.94 million
  • Price / Sales: 18.74
  • Book Value: $0.43 per share
  • Price / Book: 3.05
Profitability:
  • EBIDTA: ($34,500,000.00)
  • Net Margins: -885.84%
  • Return on Equity: -147.12%
  • Return on Assets: -115.40%
Debt:
  • Current Ratio: 4.98%
  • Quick Ratio: 4.43%
Misc:
  • Average Volume: 507,414 shs.
  • Beta: 3.62
  • Short Ratio: 14.94
 

Frequently Asked Questions for Second Sight Medical Products (NASDAQ:EYES)

What is Second Sight Medical Products' stock symbol?

Second Sight Medical Products trades on the NASDAQ under the ticker symbol "EYES."

How were Second Sight Medical Products' earnings last quarter?

Second Sight Medical Products, Inc. (NASDAQ:EYES) released its quarterly earnings data on Wednesday, May, 3rd. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.14) by $0.04. The company had revenue of $1.01 million for the quarter, compared to the consensus estimate of $1.32 million. Second Sight Medical Products had a negative return on equity of 147.12% and a negative net margin of 885.84%. View Second Sight Medical Products' Earnings History.

Where is Second Sight Medical Products' stock going? Where will Second Sight Medical Products' stock price be in 2017?

2 brokerages have issued 12-month price targets for Second Sight Medical Products' shares. Their predictions range from $16.00 to $16.00. On average, they expect Second Sight Medical Products' share price to reach $16.00 in the next year. View Analyst Ratings for Second Sight Medical Products.

Who are some of Second Sight Medical Products' key competitors?

Who are Second Sight Medical Products' key executives?

Second Sight Medical Products' management team includes the folowing people:

  • Robert J. Greenberg M.D. Ph.D., Chairman of the Board
  • Jonathan McGuire, President, Chief Executive Officer, Director
  • Thomas B. Miller, Chief Financial Officer
  • Stephen D. Okland Jr., Commercial Vice President, U.S. and Canada
  • Edward David Randolph, Vice President - Manufacturing
  • David Murray Jacques, Vice President - Research & Development
  • Gregoire Cosendai, Vice President - European Operations
  • William J. Link Ph.D., Independent Director
  • Aaron Mendelsohn, Independent Director
  • Matthew Jonathan Pfeffer CPA., Independent Director

When did Second Sight Medical Products IPO?

(EYES) raised $32 million in an initial public offering (IPO) on Wednesday, November 19th 2014. The company issued 3,500,000 shares at $9.00 per share. MDB Capital Group, LLC acted as the underwriter for the IPO.

Who owns Second Sight Medical Products stock?

Second Sight Medical Products' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Versant Venture Management LLC (7.97%), Vanguard Group Inc. (1.81%), BNP Paribas Arbitrage SA (1.24%), Van Den Berg Management I Inc. (0.53%), Geode Capital Management LLC (0.31%) and Carl Domino Inc (0.20%). Company insiders that own Second Sight Medical Products stock include Anne-Marie Juliette Ripley, Edward David Randolph, Gregg Williams and Robert J Greenberg. View Institutional Ownership Trends for Second Sight Medical Products.

Who bought Second Sight Medical Products stock? Who is buying Second Sight Medical Products stock?

Second Sight Medical Products' stock was acquired by a variety of institutional investors in the last quarter, including Versant Venture Management LLC, BNP Paribas Arbitrage SA, Vanguard Group Inc., Van Den Berg Management I Inc., Carl Domino Inc and Geode Capital Management LLC. View Insider Buying and Selling for Second Sight Medical Products.

How do I buy Second Sight Medical Products stock?

Shares of Second Sight Medical Products can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Second Sight Medical Products' stock price today?

One share of Second Sight Medical Products stock can currently be purchased for approximately $1.31.


MarketBeat Community Rating for Second Sight Medical Products (NASDAQ EYES)
Community Ranking:  2.1 out of 5 ( )
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  91
MarketBeat's community ratings are surveys of what our community members think about Second Sight Medical Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Second Sight Medical Products (NASDAQ:EYES) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $16.00 (1,121.37% upside)

Analysts' Ratings History for Second Sight Medical Products (NASDAQ:EYES)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/25/2016HC WainwrightSet Price TargetBuy$16.00N/AView Rating Details
7/26/2016Rodman & RenshawReiterated RatingBuy$16.00N/AView Rating Details
(Data available from 6/27/2015 forward)

Earnings

Earnings History for Second Sight Medical Products (NASDAQ:EYES)
Earnings by Quarter for Second Sight Medical Products (NASDAQ:EYES)
Earnings History by Quarter for Second Sight Medical Products (NASDAQ EYES)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017Q1 2017($0.14)($0.18)$1.32 million$1.01 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.17)($0.24)$1.76 million$0.72 millionViewListenView Earnings Details
11/2/2016Q316($0.16)($0.15)$2.36 million$1.20 millionViewN/AView Earnings Details
7/28/2016Q216($0.15)($0.17)$2.66 million$1.04 millionViewListenView Earnings Details
4/28/2016Q116($0.16)($0.13)$1.38 million$1.05 millionViewListenView Earnings Details
3/3/2016Q415($0.14)($0.15)$2.47 million$2.40 millionViewN/AView Earnings Details
10/29/2015Q315($0.14)($0.13)$2.05 million$2.23 millionViewListenView Earnings Details
8/4/2015Q215($0.14)($0.14)$1.73 million$2.70 millionViewN/AView Earnings Details
5/13/2015Q115($0.12)$1.70 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Second Sight Medical Products (NASDAQ:EYES)
Current Year EPS Consensus Estimate: $-0.52 EPS
Next Year EPS Consensus Estimate: $-0.53 EPS

Dividends

Dividend History for Second Sight Medical Products (NASDAQ:EYES)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Second Sight Medical Products (NASDAQ:EYES)
Insider Ownership Percentage: 50.90%
Institutional Ownership Percentage: 15.60%
Insider Trades by Quarter for Second Sight Medical Products (NASDAQ:EYES)
Institutional Ownership by Quarter for Second Sight Medical Products (NASDAQ:EYES)
Insider Trades by Quarter for Second Sight Medical Products (NASDAQ:EYES)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/7/2017Gregg WilliamsDirectorBuy4,000,000$1.00$4,000,000.00View SEC Filing  
12/1/2016Robert J GreenbergChairmanSell1,950$1.96$3,822.00View SEC Filing  
6/3/2016Edward David RandolphVPSell5,104$4.01$20,467.04View SEC Filing  
6/2/2016Robert J GreenbergChairmanSell8,571$4.10$35,141.10View SEC Filing  
4/18/2016Robert J GreenbergChairmanSell8,223$5.27$43,335.21View SEC Filing  
12/7/2015Robert J. GreenbergChairmanSell17,969$5.30$95,235.70View SEC Filing  
12/4/2015Anne-Marie Juliette RipleyVPSell2,500$5.50$13,750.00View SEC Filing  
6/4/2015Anne-Marie Juliette RipleyVPSell4,371$15.00$65,565.00View SEC Filing  
6/3/2015Robert J GreenbergCEOSell150,000$14.04$2,106,000.00View SEC Filing  
5/27/2015Anne-Marie Juliette RipleyVPSell45,629$13.04$595,002.16View SEC Filing  
3/23/2015Robert J GreenbergCEOSell100,000$13.28$1,328,000.00View SEC Filing  
11/19/2014Gregg WilliamsDirectorBuy111,111$9.00$999,999.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Second Sight Medical Products (NASDAQ:EYES)
Latest Headlines for Second Sight Medical Products (NASDAQ:EYES)
Source:
DateHeadline
streetinsider.com logoSecond Sight Medical (EYES) CFO to Resign to Pursue Other ... - StreetInsider.com
www.streetinsider.com - June 26 at 11:10 PM
finance.yahoo.com logoETFs with exposure to Second Sight Medical Products, Inc. : June 16, 2017
finance.yahoo.com - June 16 at 3:56 PM
finance.yahoo.com logoETFs with exposure to Second Sight Medical Products, Inc. : May 26, 2017
finance.yahoo.com - May 26 at 5:45 PM
prnewswire.com logoResearch Reports Initiation on Medical Equipment Stocks -- Corindus Vascular Robotics, InspireMD, Xtant Medical ... - PR Newswire (press release)
www.prnewswire.com - May 23 at 4:49 PM
businesswire.com logoSecond Sight to Present at 18th Annual B. Riley & Co. Institutional ... - Business Wire (press release)
www.businesswire.com - May 17 at 5:08 PM
finance.yahoo.com logoSecond Sight to Present at 18th Annual B. Riley & Co. Institutional Investor Conference
finance.yahoo.com - May 17 at 10:48 AM
finance.yahoo.com logoETFs with exposure to Second Sight Medical Products, Inc. : May 15, 2017
finance.yahoo.com - May 15 at 4:47 PM
finance.yahoo.com logoSecond Sight Medical Products, Inc. :EYES-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017
finance.yahoo.com - May 12 at 5:39 PM
americanbankingnews.com logoSecond Sight Medical Products Inc (EYES) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - May 11 at 9:36 PM
americanbankingnews.com logoSecond Sight Medical Products Inc (EYES) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - May 10 at 11:54 PM
seekingalpha.com logoSecond Sight Medical Products' (EYES) CEO Will McGuire on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 4 at 5:16 PM
americanbankingnews.com logoSecond Sight Medical Products (EYES) Receiving Somewhat Positive News Coverage, Report Finds
www.americanbankingnews.com - May 4 at 9:20 AM
marketbeat.com logoSecond Sight Medical Products posts 1Q loss
marketbeat.com - May 3 at 5:26 PM
finance.yahoo.com logoSecond Sight Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 3 at 4:57 PM
americanbankingnews.com logoSecond Sight Medical Products (EYES) Earns Daily News Sentiment Score of -0.10
www.americanbankingnews.com - May 1 at 4:30 PM
americanbankingnews.com logoSecond Sight Medical Products (EYES) Getting Somewhat Positive Media Coverage, Analysis Shows
www.americanbankingnews.com - April 26 at 5:56 PM
finance.yahoo.com logoSecond Sight to Discuss First Quarter 2017 Financial Results on May 3, 2017 Conference Call
finance.yahoo.com - April 25 at 11:27 AM
americanbankingnews.com logoSecond Sight Medical Products (EYES) Earns Daily Media Impact Rating of 0.20
www.americanbankingnews.com - April 20 at 5:06 PM
finance.yahoo.com logoETFs with exposure to Second Sight Medical Products, Inc. : April 19, 2017
finance.yahoo.com - April 19 at 5:02 PM
americanbankingnews.com logoSecond Sight Medical Products (EYES) Earning Somewhat Favorable Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 17 at 3:14 PM
americanbankingnews.com logoShort Interest in Second Sight Medical Products Inc (EYES) Decreases By 22.4%
www.americanbankingnews.com - April 16 at 7:38 AM
finance.yahoo.com logoSecond Sight’s Argus II Retinal Prosthesis Implanted in First Patient in Asia
finance.yahoo.com - April 13 at 11:22 AM
americanbankingnews.com logoInsider Buying: Second Sight Medical Products Inc (EYES) Director Acquires 4,000,000 Shares of Stock
www.americanbankingnews.com - April 10 at 10:57 PM
finance.yahoo.com logoSecond Sight Announces Dr. Robert Greenberg, Chairman ... - Yahoo Finance
finance.yahoo.com - April 7 at 10:05 PM
finance.yahoo.com logoETFs with exposure to Second Sight Medical Products, Inc. : April 7, 2017
finance.yahoo.com - April 7 at 5:03 PM
finance.yahoo.com logoSecond Sight Announces Dr. Robert Greenberg, Chairman, Inducted as a National Academy of Inventors Fellow
finance.yahoo.com - April 7 at 9:43 AM
americanbankingnews.com logoZacks: Brokerages Set $5.00 Target Price for Second Sight Medical Products Inc (EYES)
www.americanbankingnews.com - March 29 at 11:50 AM
finance.yahoo.com logoSecond Sight Medical Products, Inc. Announces Warrants Approved for Listing on Nasdaq With Trading Scheduled to Commence March 29 under Symbol “EYESW”
finance.yahoo.com - March 27 at 4:52 PM
finance.yahoo.com logoSECOND SIGHT MEDICAL PRODUCTS INC Financials
finance.yahoo.com - March 21 at 5:19 PM
biz.yahoo.com logoSECOND SIGHT MEDICAL PRODUCTS INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 16 at 6:28 PM
biz.yahoo.com logoSECOND SIGHT MEDICAL PRODUCTS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Di
biz.yahoo.com - March 15 at 7:43 AM
seekingalpha.com logoSecond Sight Medical Products' (EYES) CEO Will McGuire on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 10 at 11:18 AM
us.rd.yahoo.com logoSecond Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering
us.rd.yahoo.com - March 9 at 5:37 PM
biz.yahoo.com logoQ4 2016 Second Sight Medical Products Inc Earnings Release - After Market Close
us.rd.yahoo.com - March 9 at 5:37 PM
us.rd.yahoo.com logoSecond Sight Reports Fourth Quarter and Year End 2016 Financial Results
us.rd.yahoo.com - March 9 at 5:37 PM
americanbankingnews.com logoSecond Sight Medical Products Inc (EYES) Announces Quarterly Earnings Results, Misses Expectations By $0.07 EPS
www.americanbankingnews.com - March 9 at 5:06 PM
biz.yahoo.com logoSECOND SIGHT MEDICAL PRODUCTS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
biz.yahoo.com - March 7 at 11:40 AM
finance.yahoo.com logoSecond Sight Appoints David Jacques as Vice President of Research and Development
finance.yahoo.com - March 2 at 9:02 AM
finance.yahoo.com logoSecond Sight to Discuss Fourth Quarter and Year-End 2016 Financial Results on March 9, 2017 Conference Call
finance.yahoo.com - March 1 at 4:50 PM
biz.yahoo.com logoSECOND SIGHT MEDICAL PRODUCTS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - February 27 at 7:21 PM
businesswire.com logoSecond Sight Announces Professor Stanislao Rizzo Has Completed His 30 - Business Wire (press release)
www.businesswire.com - February 23 at 5:07 PM
finance.yahoo.com logoSecond Sight Announces Professor Stanislao Rizzo Has Completed His 30th Implant of the Argus II Retinal Prosthesis
finance.yahoo.com - February 22 at 9:11 AM
prnewswire.com logoSight Sciences Announces Expanding Management Team of Seasoned Medical Device Experts
www.prnewswire.com - February 16 at 5:04 PM
businesswire.com logoSecond Sight Medical Products, Inc. Announces Record Date ... - Business Wire (press release)
www.businesswire.com - February 6 at 5:09 PM
finance.yahoo.com logoSecond Sight Medical Products, Inc. Announces Record Date, Subscription Pricing, Expiration Date for Rights Offering and Effectiveness of Its Registration Statement
finance.yahoo.com - February 6 at 11:06 AM
finance.yahoo.com logoBlog Coverage Second Sight Wins Reimbursement Approval for Argus II Retinal Prosthesis System
finance.yahoo.com - February 3 at 5:31 PM
streetinsider.com logoSecond Sight Medical (EYES) Announces Positive Reimbursement Renewal Decision for Argus II in Germany
www.streetinsider.com - February 2 at 10:42 PM
uk.finance.yahoo.com logoSecond Sight Announces Positive Reimbursement Renewal Decision in Germany
us.rd.yahoo.com - February 2 at 10:42 PM
us.rd.yahoo.com logo8:03 am Second Sight Medical Products announces that the German Institute for the Hospital Remuneration System has renewed Status 1 (full approval) for the Epiretinal Prosthesis across 15 hospitals under the NUB1 innovation program
us.rd.yahoo.com - February 2 at 10:42 PM
streetinsider.com logoSecond Sight Medical (EYES) Announces Positive Reimbursement Renewal Decision for Argus II in Germany - StreetInsider.com
www.streetinsider.com - February 2 at 5:40 PM

Social

Chart

Second Sight Medical Products (EYES) Chart for Tuesday, June, 27, 2017

This page was last updated on 6/27/2017 by MarketBeat.com Staff